NewLink Genetics Investors
NewLink Genetics is a venture capital fund based in Ames, Iowa, United States, founded in 1999 The firm specializes in investing in innovative biotechnology companies that focus on developing novel therapies With an investment scale of approximately $43,400,000, NewLink Genetics aims to support early-stage companies with promising technologies The fund is committed to advancing healthcare solutions through strategic partnerships and funding opportunities NewLink Genetics continues to play a significant role in the biotechnology investment landscape
Founded Date:
1999
Last Funding Type:
Series D
Headquarters:
USA
Investors Number:
5
Employee Number:
51-100
Industry:
FemTech
Last Funding Date:
2009-07-21
Funding Status:
IPO
Investor Type:
Venture Capital Funds
Total Funding:
33594000